Few research compounds have drawn as much procurement traffic in the past two years as retatrutide. It is a single 39-residue peptide engineered to act on three receptors at once (GIP, GLP-1 and glucagon), and that triple-agonist design has made it a common reference material in receptor pharmacology, signaling and assay-development work. Demand has pulled in a long tail of sellers, and what arrives in the vial varies widely.
For a lab, the real question is not where to find a retatrutide peptide. It is how to confirm that the powder in the vial is the molecule on the label, at the stated purity and mass, free of contaminants that will skew an assay. This checklist covers what a procurement or QC lead should ask for, how to read the documents that come back, and which signals should end the conversation.
What the molecule is, and why that makes QC harder
Retatrutide is an investigational compound developed by Eli Lilly under the code LY3437943. It has not been approved by the FDA, and late-stage clinical trials are still evaluating it in metabolic disease. Anything sold outside that program is research-use-only (RUO) material, intended for in vitro laboratory work.
Structurally, it is not a simple linear peptide. Several non-proteinogenic residues and a lipid side chain sit on the backbone, and each one is a place where synthesis can go wrong.
| Parameter | Specification |
| Length | 39 amino acid residues |
| CAS number | 2381089-83-2 |
| Molecular formula | C221H342N46O68 |
| Molecular weight | ~4731.33 g/mol |
| Non-standard residues | Aib at positions 2 and 20; α-methyl-L-leucine at position 13 |
| Lipidation | C20 fatty diacid on Lys17 via an AEEA–γ-Glu linker |
| C-terminus | Amide |
Each modification creates its own family of likely impurities. An incomplete coupling at an Aib position yields a deletion sequence that can elute close to the main peak. A failed or partial acylation at Lys17 leaves a des-lipidated species with very different chromatographic behavior. Racemization, oxidation and incomplete deprotection add more. A supplier who understands the molecule knows these failure modes; a reseller of unbranded bulk lots usually does not.
The documents to demand before any purchase order
A lot-specific certificate of analysis
The certificate of analysis (COA) is the central document, and the first test is whether it is truly lot-specific. The lot number on the COA should match the lot number printed on the vial label. The test date should fall after the synthesis date and reasonably close to the ship date. If a seller sends the same COA for every order, or a COA with no lot number at all, the document says nothing about the material you received.
Ask for past batches too. Certificates for previous lots give you a track record: purity trends, net-content consistency, and whether the testing lab stays the same.
Independent third-party testing
In-house testing is a starting point, not a verification. The COA should come from an independent analytical laboratory with no financial stake in the result, and the lab should be named on the document. A COA on the seller’s own letterhead, with no outside lab identified, is a claim rather than evidence.
Reading the analytical package
HPLC purity
Reversed-phase HPLC with UV detection (typically 214–220 nm for the peptide bond) is the standard purity measurement. The reported figure is the area percent of the main peak relative to total integrated area. For a lipidated peptide of this size, research-grade material should sit at or above 99%.
When reviewing the chromatogram itself, not just the number, look for:
- The actual trace. A COA that reports “99.5%” with no chromatogram attached cannot be checked.
- Integration settings. Unusually high peak-width or threshold settings can hide small impurities near the main peak.
- Peak shape. Heavy tailing or a shoulder on the main peak often signals a co-eluting deletion or diastereomer.
- Run length. A gradient that ends shortly after the main peak elutes may miss late-eluting hydrophobic species, which matters for a fatty-acid-modified peptide.
Identity: why HPLC alone is not enough
A single sharp peak proves the sample is mostly one compound. It does not prove which compound. Identity confirmation by mass spectrometry, usually ESI-MS or MALDI-TOF, should show an observed mass consistent with the theoretical ~4731 Da, with the expected charge-state envelope for ESI. A mass shift of about 16 Da suggests oxidation. A loss matching the C20 diacid and linker points to failed lipidation. Ask whether identity was confirmed by MS or inferred from retention time against a reference standard, and weigh the answer accordingly.
Net peptide content
Purity and quantity are different measurements. A vial labeled 10 mg can contain material that is 99% pure by HPLC and still hold noticeably less than 10 mg of actual peptide, because lyophilized powder also contains counter-ions (commonly acetate or TFA) and residual water. Net-content testing, by amino acid analysis, quantitative HPLC against a standard, or nitrogen determination, tells you how much peptide is really there. For any quantitative work, such as dose-response curves or binding constants, this number matters as much as purity.
Endotoxin and sterility
For cell-based assays, bacterial endotoxin is a quiet source of bad data. Lipopolysaccharide contamination can activate innate immune signaling in many cell lines and produce responses that look like compound activity. A limulus amebocyte lysate (LAL) result, reported in EU per mg, should be on the COA. Sterility testing adds another layer of assurance for any material that will go into culture.
Heavy metals
Metal contamination from reagents or equipment can interfere with enzymatic and fluorescence assays. A heavy-metals panel rules it out.
Commercial signals worth checking
How a vendor sells also tells you a lot. When a lab is ready to buy retatrutide peptide, these are the commercial checks that separate a research supplier from a marketplace reseller:
- Transparent per-vial pricing. Pricing should be stated per vial and per size, not hidden behind “contact for quote” for standard quantities.
- RUO framing that is consistent. The listing, the label and the checkout should all say research use only. A seller using “pharmacy-grade” language or human-use marketing for an unapproved compound is signaling that it is not operating as a research supplier.
- Buyer verification. Age gating and institutional details at checkout show a vendor that knows who its customers should be.
- Normal payment channels. Payment only through odd or untraceable channels is a reason to walk away.
Red flags that should stop a purchase
- No COA, or a COA available only “on request” after payment
- One COA reused across every lot and every size
- Prices far below the rest of the market for the same mass
- No lot number on the vial
- Pre-mixed liquid offered in place of lyophilized powder
- Testing attributed to an unnamed lab
Format, storage and cold chain
Lyophilized versus pre-mixed
A peptide is most stable as a dry solid. Freeze-drying removes water under vacuum and leaves a low-moisture cake that resists hydrolysis, deamidation and microbial growth far better than any solution. Choosing to buy retatrutide as a lyophilized solid in a sealed glass vial gives the lab control over the solvent, concentration and timing of preparation. A pre-mixed solution from a seller adds unknowns: what diluent was used, how long it sat, and at what temperature.
Good material appears as a uniform white cake or powder. Collapse, visible moisture or discoloration point to a poor freeze-drying cycle or a compromised seal.
Storage on arrival
For longer-term storage, the standard guidance is a sealed vial kept at −20 °C, desiccated and protected from light. Lab practice should log receipt date, lot number and storage location so that every result traces back to a specific vial.
Shipping and the cold chain
Lyophilized peptides tolerate short ambient transit far better than solutions, but time in a truck is still time at uncontrolled temperature. Ask where the material ships from, which carrier service is used, and the cutoff for same-day dispatch. Multi-week international transit with customs holds is a real stability risk, especially in summer.
How one supplier lines up against the checklist
HEEZ Research is one example of a US-based supplier that publishes the kind of documentation described above. Its retatrutide (Reta) is sold as lyophilized white powder in sealed glass vials, in 10 mg and 20 mg sizes, priced from $100 for a single 10 mg vial.
On the analytical side, every lot is sent to an independent third-party laboratory, and lot-specific COAs are published, including those for past batches. The listed tests cover HPLC purity and identity, net content, heavy metals, sterility and endotoxin. The stated purity specification is ≥99% by HPLC, and recent published lot results came in at 99.77% for the 10 mg vial and 99.60% for the 20 mg vial.
On the commercial side, orders placed before 2 PM ET Monday through Friday (1 PM ET Saturday) ship the same day from the USA by UPS 2nd Day Air or UPS Overnight, and nothing ships on Sundays. Buyers must be 21 or older, and checkout asks for an institution name and a matching institutional email. All sales are final, and the material is sold for in vitro research use only, not for human or veterinary use.
| Size | What it suits | Note |
| 10 mg, single vial | Pilot assays, method development, first-pass identity checks | From $100 |
| 10 mg, Buy 2 + Get 1 FREE | Replicate experiments across one study | 3 vials for $200 |
| 10 mg, Buy 3 + Get 2 FREE | Longer studies where lot consistency across vials matters | 5 vials for $300 |
| 20 mg vial | Larger working stocks, higher-concentration preparations | Separate lot COA published |
For labs running related receptor work, the same documentation standard applies across the vendor’s wider catalog of research-grade peptides, so one QC review process can cover several compounds.
A short procurement checklist
Before approving an order, the reviewer should answer yes to each:
- The COA lot number matches the vial label.
- A named, independent lab did the testing.
- HPLC purity is ≥99%, chromatogram attached.
- Identity was confirmed, ideally by MS, against ~4731 Da.
- Net content was measured, not assumed.
- Endotoxin, sterility and heavy metals are reported.
- The product is lyophilized in a sealed vial.
- Shipping is domestic and fast.
- Labeling is consistently research use only.
FAQ
What purity should a research-grade retatrutide peptide have?
At least 99% by reversed-phase HPLC, backed by a chromatogram and a lot-specific COA, with identity and net content also reported.
Is an HPLC result enough to confirm identity?
No. HPLC shows how much of the sample is a single component, not which component it is. Mass spectrometry confirms that the observed mass matches the theoretical ~4731 Da molecule.
Why does net peptide content differ from the vial’s labeled mass?
The powder also contains counter-ions and residual moisture. Net-content testing measures the actual peptide, which quantitative work depends on.
Why does endotoxin matter for an in vitro study?
Endotoxin can trigger signaling responses in many cell lines, producing effects that can be mistaken for compound activity. A low LAL result protects cell-based data from that artifact.
Should a lab accept pre-mixed retatrutide?
Better not. Lyophilized powder is more stable, while a pre-mixed solution carries unknown history.
How should lyophilized retatrutide be stored?
In its sealed vial, protected from light, at −20 °C with desiccation for longer-term storage. Log the lot number and receipt date for traceability.
What is the biggest red flag when sourcing retatrutide?
A COA with no lot number, or the same COA reused for every batch. Without lot-level documentation, there is no way to know what the vial actually contains.
